Is Adma Biologics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ADMA) stock is to Strong Buy ADMA stock.
Out of 3 analysts, 2 (66.67%) are recommending ADMA as a Strong Buy, 1 (33.33%) are recommending ADMA as a Buy, 0 (0%) are recommending ADMA as a Hold, 0 (0%) are recommending ADMA as a Sell, and 0 (0%) are recommending ADMA as a Strong Sell.
What is ADMA's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.
What is ADMA's Price Target?
According to 3 Wall Street analysts that have issued a 1 year ADMA price target, the average ADMA price target is $5.67, with the highest ADMA stock price forecast at $6.00 and the lowest ADMA stock price forecast at $5.00.
On average, Wall Street analysts predict that Adma Biologics's share price could reach $5.67 by Aug 10, 2024. The average Adma Biologics stock price prediction forecasts a potential upside of 57.86% from the current ADMA share price of $3.59.
What is ADMA's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: ADMA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.